Skip to main content
. 2022 Jul 29;16:970350. doi: 10.3389/fnins.2022.970350

TABLE 1.

Cell sources for regenerative central nervous system (CNS) therapy.

Source of cells Accessibility Ethical concerns Tumorigenic Autologous Nervous system-derived
NSPCs Low Moderate Sometimes Sometimes Yes
ESCs Low Significant Yes No No
iPSCs High None Yes Yes No
MSCs High None No Yes No
HSCs High None No Yes No
DPSCs High None No Yes No
ENSCs High None No Yes Yes
SAT-NSCs High None No Yes Yes

NSPCs, neural stem/progenitor cells; ESCs, embryonic stem cells; iPSCs, induced pluripotent stem cells; MSCs, mesenchymal stem cells; HSCs, hematopoietic stem cells; DPSCs, dental pulp stem cells; ENSCs, enteric neuronal stem cells; SAT-NSCs, subcutaneous adipose tissue–neural stem cells.